Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Resilience, burnout and coping mechanisms in UK doctors: a cross-sectional study.

McKinley N, McCain RS, Convie L, Clarke M, Dempster M, Campbell WJ, Kirk SJ.

BMJ Open. 2020 Jan 27;10(1):e031765. doi: 10.1136/bmjopen-2019-031765.

2.

Resilience in medical doctors: a systematic review.

McKinley N, Karayiannis PN, Convie L, Clarke M, Kirk SJ, Campbell WJ.

Postgrad Med J. 2019 Mar;95(1121):140-147. doi: 10.1136/postgradmedj-2018-136135. Epub 2019 Mar 29.

PMID:
30926716
3.

Correspondence.

Convie L, McCain RS, McKinley N, Kirk SJ, Campbell WJ, Clarke M.

Br J Surg. 2019 Mar;106(4):508. doi: 10.1002/bjs.11105. No abstract available.

PMID:
30811053
4.

Evaluating interventions for informed consent for surgery (ICONS): Protocol for the development of a core outcome set.

Convie LJ, McCain S, Campbell J, Kirk SJ, Clarke M.

Trials. 2018 Nov 6;19(1):609. doi: 10.1186/s13063-018-2986-8.

5.

A study of the relationship between resilience, burnout and coping strategies in doctors.

McCain RS, McKinley N, Dempster M, Campbell WJ, Kirk SJ.

Postgrad Med J. 2017 Aug 9. pii: postgradmedj-2016-134683. doi: 10.1136/postgradmedj-2016-134683. [Epub ahead of print]

PMID:
28794171
6.

DO THE PUBLIC GET WHAT THE PUBLIC WANTS IN NORTHERN IRELAND HEALTH AND SOCIAL CARE?

McCain RS, Kirk J, Campbell WJ, Kirk SJ.

Ulster Med J. 2017 Jan;86(1):45-46. No abstract available.

7.
8.

Individualized 131I-mIBG therapy in the management of refractory and relapsed neuroblastoma.

George SL, Falzone N, Chittenden S, Kirk SJ, Lancaster D, Vaidya SJ, Mandeville H, Saran F, Pearson AD, Du Y, Meller ST, Denis-Bacelar AM, Flux GD.

Nucl Med Commun. 2016 May;37(5):466-72. doi: 10.1097/MNM.0000000000000470.

9.

A novel approach to improve undergraduate surgical teaching.

Baker RC, Spence RA, Boohan M, Dorman A, Stevenson M, Kirk SJ, McGlade K.

Ulster Med J. 2015 Jan;84(1):30-6.

10.

Illness perception clusters at diagnosis predict psychological distress among women with breast cancer at 6 months post diagnosis.

McCorry NK, Dempster M, Quinn J, Hogg A, Newell J, Moore M, Kelly S, Kirk SJ.

Psychooncology. 2013 Mar;22(3):692-8. doi: 10.1002/pon.3054. Epub 2012 Mar 4.

PMID:
22389291
11.

Risk stratification as a means of reducing the burden of follow-up after completion of initial treatment for breast cancer.

Magee CE, Hillan JA, Badger SA, Kennedy RJ, Kirk SJ.

Surgeon. 2011 Apr;9(2):61-4. doi: 10.1016/j.surge.2010.06.009. Epub 2010 Jul 31.

PMID:
21342668
12.

The barrier method as a new tool to assist in career selection: covert observational study.

McCain RS, Harris AR, McCallion K, Campbell WJ, Kirk SJ.

BMJ. 2010 Dec 15;341:c6968. doi: 10.1136/bmj.c6968.

13.

Addition of drug/s to a chemotherapy regimen for metastatic breast cancer.

Butters DJ, Ghersi D, Wilcken N, Kirk SJ, Mallon PT.

Cochrane Database Syst Rev. 2010 Nov 10;(11):CD003368. doi: 10.1002/14651858.CD003368.pub3. Review.

PMID:
21069675
14.

Biogenesis of secretory organelles during B cell differentiation.

Kirk SJ, Cliff JM, Thomas JA, Ward TH.

J Leukoc Biol. 2010 Feb;87(2):245-55. doi: 10.1189/jlb.1208774. Epub 2009 Nov 4.

PMID:
19889725
15.

Mesenteric artery occlusion secondary to activated protein C resistance: a life-threatening combination.

Scally N, O'Donnell ME, McClintock C, Allen M, Kirk SJ, Dolan S.

Angiology. 2007 Dec-2008 Jan;58(6):768-71. doi: 10.1177/0003319707304566.

PMID:
18216386
16.

COPII under the microscope.

Kirk SJ, Ward TH.

Semin Cell Dev Biol. 2007 Aug;18(4):435-47. Epub 2007 Jul 12. Review.

PMID:
17693103
17.

18fluorodeoxyglucose positron emission tomography in the prediction of relapse in patients with high-risk, clinical stage I nonseminomatous germ cell tumors: preliminary report of MRC Trial TE22--the NCRI Testis Tumour Clinical Study Group.

Huddart RA, O'Doherty MJ, Padhani A, Rustin GJ, Mead GM, Joffe JK, Vasey P, Harland SJ, Logue J, Daugaard G, Hain SF, Kirk SJ, MacKewn JE, Stenning SP; NCRI Testis Tumour Clinical Study Group.

J Clin Oncol. 2007 Jul 20;25(21):3090-5.

PMID:
17634488
18.

Randomized trial of two or five computed tomography scans in the surveillance of patients with stage I nonseminomatous germ cell tumors of the testis: Medical Research Council Trial TE08, ISRCTN56475197--the National Cancer Research Institute Testis Cancer Clinical Studies Group.

Rustin GJ, Mead GM, Stenning SP, Vasey PA, Aass N, Huddart RA, Sokal MP, Joffe JK, Harland SJ, Kirk SJ; National Cancer Research Institute Testis Cancer Clinical Studies Group.

J Clin Oncol. 2007 Apr 10;25(11):1310-5.

PMID:
17416851
19.

Natural history of asymptomatic bile duct stones at time of cholecystectomy.

Caddy GR, Kirby J, Kirk SJ, Allen MJ, Moorehead RJ, Tham TC.

Ulster Med J. 2005 Sep;74(2):108-12.

20.

Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial.

Oliver RT, Mason MD, Mead GM, von der Maase H, Rustin GJ, Joffe JK, de Wit R, Aass N, Graham JD, Coleman R, Kirk SJ, Stenning SP; MRC TE19 collaborators and the EORTC 30982 collaborators.

Lancet. 2005 Jul 23-29;366(9482):293-300.

21.

Radial scar, complex sclerosing lesion and risk of breast cancer. Analysis of 175 cases in Northern Ireland.

Patterson JA, Scott M, Anderson N, Kirk SJ.

Eur J Surg Oncol. 2004 Dec;30(10):1065-8.

PMID:
15522552
22.

Malignancy-associated changes in lactiferous duct epithelium.

Anderson N, Houghton J, Kirk SJ, Frank D, Ranger-Moore J, Alberts DS, Thompson D, Bartels PH.

Anal Quant Cytol Histol. 2003 Apr;25(2):63-72.

PMID:
12746974
23.

Hydroxymethyl pentylcyclohexene- carboxaldehyde (Lyral) as a fragrance allergen in the UK.

Baxter KF, Wilkinson SM, Kirk SJ.

Contact Dermatitis. 2003 Feb;48(2):117-8. No abstract available.

PMID:
12694220
24.

Mucosal barrier function and the commensal flora.

Kennedy RJ, Kirk SJ, Gardiner KR.

Gut. 2002 Mar;50(3):441-2. No abstract available.

25.

Probiotics in IBD.

Kennedy RJ, Kirk SJ, Gardiner KR.

Gut. 2001 Dec;49(6):873. No abstract available.

26.

Probiotics (Br J Surg 2001; 88: 161-2).

Kennedy RJ, Kirk SJ, Gardiner KR.

Br J Surg. 2001 Jul;88(7):1018-9. No abstract available.

PMID:
11442548
27.

Prospective evaluation of the morbidity of axillary clearance for breast cancer (Br J Surg 2001; 88: 114-7).

Kennedy RJ, Bradley J, Parks RW, Kirk SJ.

Br J Surg. 2001 Jun;88(6):891. No abstract available.

PMID:
11412274
28.

Probiotic therapy fails to improve gut permeability in a hapten model of colitis.

Kennedy RJ, Hoper M, Deodhar K, Kirk SJ, Gardiner KR.

Scand J Gastroenterol. 2000 Dec;35(12):1266-71.

PMID:
11199365
29.

Tumour necrosis factor inhibitors reduce the acute-phase response in hapten-induced colitis.

Armstrong AM, Foulkes R, Jennings G, Gannon C, Kirk SJ, Gardiner KR.

Br J Surg. 2001 Feb;88(2):235-40.

PMID:
11167873
30.

Interleukin 10-deficient colitis: new similarities to human inflammatory bowel disease.

Kennedy RJ, Hoper M, Deodhar K, Erwin PJ, Kirk SJ, Gardiner KR.

Br J Surg. 2000 Oct;87(10):1346-51.

PMID:
11044159
31.

Oral administration of inducible nitric oxide synthase inhibitors reduces nitric oxide synthesis but has no effect on the severity of experimental colitis.

Armstrong AM, Campbell GR, Gannon C, Kirk SJ, Gardiner KR.

Scand J Gastroenterol. 2000 Aug;35(8):832-8.

PMID:
10994622
32.

Promotion of a favorable gut flora in inflammatory bowel disease.

Kennedy RJ, Kirk SJ, Gardiner KR.

JPEN J Parenter Enteral Nutr. 2000 May-Jun;24(3):189-95. Review.

PMID:
10850949
33.

Pregnancy associated endometriosis with pronounced stromal myxoid change.

McCluggage WG, Kirk SJ.

J Clin Pathol. 2000 Mar;53(3):241-2.

34.

Post traumatic pseudoaneurysm of an intrasplenic segmental artery; a mechanism of delayed splenic rupture.

Kennedy JA, Majury C, Kelly I, Kirk SJ.

Injury. 1999 Oct;30(8):535-6. No abstract available.

PMID:
10707208
35.

Fine needle aspiration cytology (FNAC) of mammary granular cell tumour: a report of three cases.

McCluggage WG, Sloan S, Kenny BD, Alderdice JM, Kirk SJ, Anderson NH.

Cytopathology. 1999 Dec;10(6):383-9.

PMID:
10607009
36.

Kupffer cell blockade, tumour necrosis factor secretion and survival following endotoxin challenge in experimental biliary obstruction.

Kennedy JA, Lewis H, Clements WD, Kirk SJ, Campbell G, Halliday MI, Rowlands BJ.

Br J Surg. 1999 Nov;86(11):1410-4.

PMID:
10583287
37.

Characterization of the Kupffer cell response to exogenous endotoxin in a rodent model of obstructive jaundice.

Kennedy JA, Clements WD, Kirk SJ, McCaigue MD, Campbell GR, Erwin PJ, Halliday MI, Rowlands BJ.

Br J Surg. 1999 May;86(5):628-33.

PMID:
10361183
38.

Tumour necrosis factor and inflammatory bowel disease.

Armstrong AM, Gardiner KR, Kirk SJ, Halliday MI, Rowlands BJ.

Br J Surg. 1997 Aug;84(8):1051-8. Review.

PMID:
9278640
39.

Necrotizing fasciitis: two cases in a single family.

Gilliland R, Whiteside M, Kirk SJ, Moorehead RJ.

Ulster Med J. 1996 May;65(1):89-90. No abstract available.

40.

Endotoxaemia and cytokine production in experimental colitis.

Neilly PJ, Gardiner KR, Kirk SJ, Jennings G, Anderson NH, Elia M, Rowlands BJ.

Br J Surg. 1995 Nov;82(11):1479-82.

PMID:
8535797
41.

Topical glutamine therapy in experimental inflammatory bowel disease.

Neilly PJ, Gardiner KR, Kirk SJ, O'hare M, Jennings G, Anderson NH, Elia M, Rowlands BJ.

Clin Nutr. 1995 Oct;14(5):283-7.

PMID:
16843944
42.

Manipulation of the L-arginine-nitric oxide pathway in experimental colitis.

Neilly PJ, Kirk SJ, Gardiner KR, Anderson NH, Rowlands BJ.

Br J Surg. 1995 Sep;82(9):1188-91. Erratum in: Br J Surg 1995 Dec;82(12):1696.

PMID:
7551992
43.

Metabolic effects of arginine in a healthy elderly population.

Hurson M, Regan MC, Kirk SJ, Wasserkrug HL, Barbul A.

JPEN J Parenter Enteral Nutr. 1995 May-Jun;19(3):227-30. Erratum in: JPEN J Parenter Enteral Nutr 1995 Jul-Aug;19(4):329.

PMID:
8551652
44.

Novel substrates to maintain gut integrity.

Gardiner KR, Kirk SJ, Rowlands BJ.

Nutr Res Rev. 1995 Jan;8(1):43-66. doi: 10.1079/NRR19950006. No abstract available.

PMID:
19094279
45.

The L-arginine/nitric oxide pathway--biological properties and therapeutic applications.

Neilly PJ, Kirk SJ, Gardiner KR, Rowlands BJ.

Ulster Med J. 1994 Oct;63(2):193-200. Review. No abstract available.

46.

Modulation of immune function and weight loss by L-arginine in obstructive jaundice in the rat.

Kennedy JA, Kirk SJ, McCrory DC, Halliday MI, Barclay GR, Rowlands BJ.

Br J Surg. 1994 Aug;81(8):1199-201.

PMID:
7953359
47.

Arginine stimulates wound healing and immune function in elderly human beings.

Kirk SJ, Hurson M, Regan MC, Holt DR, Wasserkrug HL, Barbul A.

Surgery. 1993 Aug;114(2):155-9; discussion 160.

PMID:
8342121
48.

A rare late complication of breast cancer treatment.

Clements WD, Kirk SJ, Spence RA.

Br J Clin Pract. 1993 Jul-Aug;47(4):219-20.

PMID:
8260346
49.

Tumor necrosis factor-alpha inhibits in vivo collagen synthesis.

Regan MC, Kirk SJ, Hurson M, Sodeyama M, Wasserkrug HL, Barbul A.

Surgery. 1993 Feb;113(2):173-7.

PMID:
8430365
50.

Sepsis impairs gut amino acid absorption.

Sodeyama M, Gardiner KR, Regan MC, Kirk SJ, Efron G, Barbul A.

Am J Surg. 1993 Jan;165(1):150-4.

PMID:
8418691

Supplemental Content

Support Center